Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Dermatology and Therapy|February 8, 2025
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design OverviewJohn R Ingram, Georgios Kokolakis, Barry M McGrath, et al.BMJ Open|February 6, 2024
Protocol of a scoping review of outcome domains in dermatologyUmer Nadir, Areeba Ahmed, Michael D Yi, et al.American Journal of Clinical Dermatology|March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt TreatmentAntonio Martorell, John R Ingram, Christopher J Sayed, et al.The British Journal of Dermatology|October 12, 2023
Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): a prospective cohort studyJohn R Ingram, Janine Bates, Rebecca Cannings-John, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2015
A novel lung explant model for the ex vivo study of efficacy and mechanisms of anti-influenza drugsBen Nicholas, Karl J Staples, Stefan Moese, et al.Dermatology and Therapy|May 15, 2025
Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 TrialsJohn R Ingram, Jacek C Szepietowski, Lukasz Matusiak, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|June 11, 2026
Immunothrombosis promotes the interaction between neutrophils and synovial fibroblasts in rheumatoid arthritisEvangelos Papadimitriou, Anastasia-Maria Natsi, Victoria Tsironidou, et al.Plos Pathogens|February 17, 2021
Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategyIrene Pila-Castellanos, Diana Molino, Joe McKellar, et al.Plos Pathogens|March 31, 2021
Correction: Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategyIrene Pila-Castellanos, Diana Molino, Joe McKellar, et al.Mabs|November 30, 2023
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseasesMaarten van der Linden, Sangeeta Kumari, Daphne Montizaan, et al.Pageof 12